Hsin-Yuan Cheng

Hsin-Yuan Cheng is a Senior Principal Scientist at Allogene Therapeutics since December 2018, previously holding the position of Principal Scientist. Prior experience includes a Scientist role at Compugen from June 2015 to November 2018, focusing on in vitro assay development and expression analysis, as well as in vivo and ex vivo studies. Hsin-Yuan served as a Postdoctoral Fellow at the La Jolla Institute for Allergy and Immunology from April 2010 to May 2015, conducting research on the regulation of Tregs in atherosclerosis and the impact of cholesterol on T cell differentiation. Educational qualifications include a Ph.D. in Cell and Molecular Physiology from the University of North Carolina at Chapel Hill, a Master's in Molecular Medicine from National Taiwan University, and a Bachelor's Degree in Agricultural Chemistry, also from National Taiwan University.